256 - Science of COVID-19 Vaccines

Saturday, October 22, 2022

1:45 PM – 3:00 PM US ET

Location: 145 AB

Watch the live stream on the conference website.

All relevant financial disclosures have been mitigated.

Moderator(s)

Nadine Rouphael, MD

Professor of Medicine- Director of the Hope Clinic
Division of Infectious Diseases, Department of Medicine
Emory University School of Medicine
Atlanta, Georgia, United States

Disclosure(s): Emmes: Advisor/Consultant (Ongoing); ICON: Advisor/Consultant (Ongoing)
Lisa Jackson, MD, MPH

Senior Investigator
Kaiser Permanente Washington Health Research Institute
Seattle, WA, United States

Disclosure(s): No financial relationships to disclose

Faculty(s)

Ali Ellebedy, PHD

Associate Professor
Washington University School of Medicine in St. Louis

Disclosure(s): Abbvie: Grant/Research Support (Terminated); Moderna, Inc.: Grant/Research Support (Ongoing), Honoraria (Ongoing); RGAX: Advisor/Consultant (Ongoing)

Slides
Peter Dull, MD

Deputy Director
Bill & Melinda Gates Foundation
Seattle, WA, United States

Disclosure(s): No financial relationships to disclose

Slides
Yonatan Grad, MD, PHD

Melvin J. and Geraldine L. Glimcher Associate Professor
Immunology and Infectious Diseases
Harvard T.H. Chan School of Public Health
Boston, MA, United States

Disclosure(s): Day Zero Diagnostics Inc.: Board Member (Ongoing); Decoy therapeutics: Advisor/Consultant (Ongoing); GSK: Advisor/Consultant (Terminated); Quidel: Advisor/Consultant (Terminated)

Slides

Disclosure(s):

Nadine Rouphael, MD: Emmes: Advisor/Consultant (Ongoing); ICON: Advisor/Consultant (Ongoing)

Lisa Jackson, MD, MPH: No financial relationships to disclose

Ali Ellebedy, PHD: Abbvie: Grant/Research Support (Terminated); Moderna, Inc.: Grant/Research Support (Ongoing), Honoraria (Ongoing); RGAX: Advisor/Consultant (Ongoing)

Peter Dull, MD: No financial relationships to disclose

Yonatan H. Grad, MD, PHD: Day Zero Diagnostics Inc.: Board Member (Ongoing); Decoy therapeutics: Advisor/Consultant (Ongoing); GSK: Advisor/Consultant (Terminated); Quidel: Advisor/Consultant (Terminated)

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 contact hours of pharmacy CE
ACPE Number: JA0007082-0000-22-002-L01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe the role of cellular and tissue immunology in the creation of the COVID-19 vaccine;
describe the correlates of protection for the COVID-19 vaccine;
discuss the impact immune history and variants on the COVID-19 vaccine

Presentations:

1:45 PM – 2:10 PM US ET

Beyond the Antibodies: Role of Cellular and Tissue Immunology
Speaker: Ali Ellebedy, PHD – Washington University School of Medicine in St. Louis
2:10 PM – 2:35 PM US ET

Correlates of Protection - Learnings from COVID-19
Speaker: Peter Dull, MD – Bill & Melinda Gates Foundation
2:35 PM – 3:00 PM US ET

The Impact of Immune History and Variant on SARS-CoV-2 Viral Kinetics and Infection Rebound
Speaker: Yonatan H. Grad, MD, PHD – Harvard T.H. Chan School of Public Health